\
&
Contact us
\
&
Contact us
Published on | 4 years ago
Programmes ERCPrincipal Investigators with an ERC grant that is running or ended less than 12 months before 1 January of the call year are eligible to participate in an ERC Proof of Concept Grant. The results of the 2020 Proof of Concept call (3rd cut-off 17 September 2020) were published. In total 55 ERC grant holders received a Proof of Concept grant including two researchers based at Flemish host institutions:
FWO press release – Onderzoekers vertellen: Kevin Braeckmans
Related news article
ERC - Number of proposals submitted Proof of Concept 2020 call, 3rd cut-off
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
